Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Nuvalent Inc | 2,697,267 | 2,697,267 | 0 | $204.61M | $275.93M | 28.71% | +$71.32M |
| Newamsterdam Pharma Company ORDINARY SHARES | 10,473,913 | 10,473,913 | 0 | $201.20M | $173.87M | 18.09% | -$27.34M |
| Disc Medicine, Inc.(IRON) | 1,795,735 | 1,795,735 | 0 | $80.93M | $88.24M | 9.18% | +$7.31M |
| Dianthus Therapeutics, Inc.(DNTH) | 3,013,423 | 3,013,423 | 0 | $77.99M | $82.51M | 8.58% | +$4.52M |
| Savara Inc.(SVRA) | 14,565,457 | 14,565,457 | 0 | $58.70M | $61.76M | 6.43% | +$3.06M |
| Pharvaris N V COM | 3,303,381 | 3,303,381 | 0 | $62.10M | $61.18M | 6.36% | -$924.9K |
| Annexon, Inc.(ANNX) | 8,449,208 | 8,449,748 | +540 | $41.40M | $50.02M | 5.20% | +$8.62M |
| Solid Biosciences Inc | 4,034,582 | 4,034,582 | 0 | $22.88M | $28.12M | 2.93% | +$5.24M |
| Tango Therapeutics, Inc.(TNGX) | 2,892,663 | 2,712,008 | -180,655 | $24.82M | $20.88M | 2.17% | -$3.94M |
| Kyverna Therapeutics, Inc.(KYTX) | 3,368,370 | 3,368,370 | 0 | $25.26M | $16.47M | 1.71% | -$8.79M |
| Mersana Therapeutics Inc | 8,663,673 | 8,663,673 | 0 | $17.41M | $16.37M | 1.70% | -$1.04M |
| Cabaletta Bio, Inc.(CABA) | 1,649,964 | 2,760,888 | +1,110,924 | $12.34M | $13.03M | 1.36% | +$689.7K |
| X4 Pharmaceuticals, Inc.(XFOR) | 16,915,784 | 16,915,784 | 0 | $9.81M | $11.32M | 1.18% | +$1.51M |
| Century Therapeutics, Inc.(IPSC) | 5,410,361 | 5,410,361 | 0 | $13.80M | $9.25M | 0.96% | -$4.54M |
| Atea Pharmaceuticals, Inc.(AVIR) | 2,485,638 | 2,485,638 | 0 | $8.23M | $8.33M | 0.87% | +$99.4K |
| Cidara Therapeutics Inc | 0 | 703,080 | +703,080 | $0 | $7.56M | 0.79% | +$7.56M |
| Rapid Micro Biosystems, Inc.CL A(RPID) | 8,434,560 | 8,434,560 | 0 | $5.57M | $7.51M | 0.78% | +$1.94M |
| C4 Therapeutics, Inc.(CCCC) | 1,111,910 | 1,111,910 | 0 | $5.14M | $6.34M | 0.66% | +$1.20M |
| Syros Pharmaceuticals Inc | 2,749,808 | 2,750,151 | +343 | $14.19M | $5.91M | 0.62% | -$8.28M |
| Nautilus Biotechnology, Inc.(NAUT) | 2,000,000 | 2,000,000 | 0 | $4.68M | $5.70M | 0.59% | +$1.02M |
| Marinus Pharmaceuticals Inc | 2,267,680 | 2,693,380 | +425,700 | $2.65M | $4.74M | 0.49% | +$2.09M |
| Xilio Therapeutics, Inc.(XLO) | 3,785,450 | 4,566,817 | +781,367 | $3.59M | $3.60M | 0.37% | +$10.6K |
| Invivyd, Inc.(IVVD) | 1,799,595 | 1,799,595 | 0 | $1.98M | $1.84M | 0.19% | -$144.0K |
| Newamsterdam Pharma CompanyW EXP 99 99 999 *W EXP 99/99/999 | 100,000 | 100,000 | 0 | $872.0K | $700.0K | 0.07% | -$172.0K |
| Aclaris Therapeutics, Inc.(ACRS) | 1,000,000 | 0 | -1,000,000 | $1.10M | $0 | — | -$1.10M |
| Arcutis Biotherapeutics, Inc.(ARQT) | 1,030,703 | 0 | -1,030,703 | $9.59M | $0 | — | -$9.59M |